comparison of two technique of sonography and fluoroscopy in epidural steroid injection for lumbar back pain

Ultrasound-guided vs. fluoroscopic-guided epidural steroid injection in lower lumbar radicular pain: a prospective, randomized, single-blind clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016091629832N1

Enrollment

Registered

2017-05-13

Start date

2016-10-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radicular lumbar pain. Radiculopathy

Interventions

Intervention 1: intervention group: epidural injection of 8ml triamcinolone, 2ml marcaine .05% and 1 ml non-ionic contrast agent under the guide of ultrasound. Intervention 2: Control group: epidural

Treatment - Other

intervention group: epidural injection of 8ml triamcinolone, 2ml marcaine .05% and 1 ml non-ionic contrast agent under the guide of ultrasound

Control group: epidural injection of 8ml triamcinolone, 2ml marcaine .05% and 1 ml non-ionic contrast agent under the guide of flouroscope

Eligibility

Sex/Gender

All

Age

15 Years to 70 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age between 15-70 years; diagnosis of intervertebral disc herniation or canal stenosis confirmed by clinical history & examination, EMG, CT or MRI tests. exclusion criteria: systemic inflammatory diseases; being under treatment by anti-coagulants; need to consume NSAIDs; uncontrolled diabetes; history of allergic reaction to contrast agents; history of injection or surgery during past 3 months; infection; skin defect in injection site; psychotic problems.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Contrast distribution pattern. Timepoint: during the intervention. Method of measurement: compatible/ non-compatible with the research standard protocol.	—

Secondary

Measure	Time frame
Pain. Timepoint: Before the intervention - 48 hrs and two weeks after the intervention. Method of measurement: 0-10 based on VAS.;Function. Timepoint: Before the intervention - 48 hrs and two weeks after the intervention. Method of measurement: 0-100 basedon ODI.;Patients satisfaction. Timepoint: 48 hrs and two weeks after the intervention. Method of measurement: 0-5 based on PSQ.;Adverse effects. Timepoint: During the intervention - 48 hrs and two weeks after the intervention. Method of measurement: examination.;Duration of the injetion. Timepoint: During the intervention. Method of measurement: based on seconds using cronometer.	—

Measure

Time frame

Pain. Timepoint: Before the intervention - 48 hrs and two weeks after the intervention. Method of measurement: 0-10 based on VAS.;Function. Timepoint: Before the intervention - 48 hrs and two weeks after the intervention. Method of measurement: 0-100 basedon ODI.;Patients satisfaction. Timepoint: 48 hrs and two weeks after the intervention. Method of measurement: 0-5 based on PSQ.;Adverse effects. Timepoint: During the intervention - 48 hrs and two weeks after the intervention. Method of measurement: examination.;Duration of the injetion. Timepoint: During the intervention. Method of measurement: based on seconds using cronometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Glini-moghaddam

Shahid Beheshti University of Medical Sciences

homeopathylover@yahoo.com+98 21 2261 2252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026